How to Get Finasteride in Illinois

What Is Finasteride and Why Do Illinois Residents Seek It?

Finasteride is a type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). DHT is the androgen most responsible for follicle miniaturization in androgenetic alopecia (AGA) and for prostate growth in benign prostatic hyperplasia (BPH). The FDA approved 1 mg finasteride (Propecia) for male AGA in 1997 and 5 mg finasteride (Proscar) for BPH in 1992. Generic versions of both are now widely available and significantly cheaper than brand-name products.

Illinois ranks among the ten most populous states in the United States, and its metropolitan centers, especially Chicago, Rockford, and Springfield, have large concentrations of dermatology and urology practices. Still, wait times at in-person specialty clinics for a non-urgent hair-loss consultation can run 6 to 12 weeks. Telehealth has filled that gap. A 2023 survey published in JAMA Dermatology found that 61% of men seeking AGA treatment preferred a digital-first consultation when one was available. [1]

The clinical case for finasteride is well-established. Kaufman et al. (N=1,553, 2-year randomized controlled trial) reported a 48% increase in hair count and a 2.2-point improvement on a 7-point photographic rating scale in men receiving 1 mg finasteride daily versus placebo. [2] For BPH, the 4-year PLESS trial (N=3,040) demonstrated a 57% reduction in the risk of acute urinary retention in men assigned to 5 mg finasteride compared with placebo. [3]

Illinois Legal Framework for Prescribing and Dispensing Finasteride

Illinois law permits licensed physicians (MDs and DOs), nurse practitioners, and physician assistants to prescribe finasteride to patients they have evaluated. The Illinois Nurse Practitioner Act (225 ILCS 65) grants full prescriptive authority to Advanced Practice Registered Nurses (APRNs), meaning NPs in Illinois do not require a supervising physician to write a finasteride prescription. Physician assistants operate under the Illinois Physician Assistant Practice Act (225 ILCS 95) and may prescribe controlled and non-controlled medications within their delegated scope; finasteride is not a controlled substance, so PA prescribing authority here is broad.

Telehealth prescribing follows the Illinois Telehealth Act (Public Act 101-0587), which requires a valid patient-provider relationship but does not mandate an in-person visit before a prescription is issued for a non-controlled substance. This means a synchronous video visit or, in some clinic protocols, a comprehensive asynchronous intake questionnaire combined with photographic assessment, can satisfy the clinical encounter requirement for finasteride. [4]

Illinois Medicaid (administered by HFS, the Illinois Department of Healthcare and Family Services) covers finasteride for both AGA and BPH with prior authorization. The prior authorization process is described in detail in the H2 section below.

Step-by-Step: How to Get a Finasteride Prescription in Illinois

Getting finasteride in Illinois follows a short, predictable sequence regardless of whether you choose in-person or telehealth care.

Step 1. Choose your care setting. In-person options include primary care physicians, dermatologists, and urologists. Telehealth options include Illinois-licensed platforms that operate within the state. Any platform prescribing to an Illinois address must hold an Illinois telehealth registration and employ or contract with an Illinois-licensed prescriber.

Step 2. Complete the clinical intake. For AGA, the provider will typically assess your Norwood-Hamilton scale classification, review photos of your scalp, ask about family history of hair loss, and screen for contraindications (liver disease, hypersensitivity to finasteride, and, for female patients of reproductive potential, pregnancy or plans to conceive). For BPH, the provider will review urinary symptom scores, typically using the International Prostate Symptom Score (IPSS), and may require a baseline PSA.

Step 3. Receive the prescription. Illinois pharmacies accept e-prescriptions transmitted via HIPAA-compliant electronic prescribing systems. Paper prescriptions are no longer standard for most outpatient workflows, though they remain legal.

Step 4. Fill at your preferred pharmacy. You may use a retail chain (Walgreens, CVS, Jewel-Osco pharmacy counters), an independent community pharmacy, a mail-order pharmacy, or a 503A compounding pharmacy for customized formulations. Generic 1 mg finasteride costs approximately $15 to $35 per 30-day supply at major Illinois retail pharmacies without insurance, though GoodRx-type discount programs can reduce this further.

Step 5. Pick up or receive delivery. In-store pickup is same-day. Mail-order from most Illinois-licensed pharmacy benefit managers runs 2 to 5 business days for standard shipping, or 1 to 2 business days for expedited.

The HealthRX clinical team uses a standardized Illinois patient pathway that flags three decision points: (1) AGA vs. BPH indication, because the dose differs (1 mg vs. 5 mg); (2) Medicaid vs. commercial insurance vs. self-pay, because prior authorization timelines differ significantly; and (3) standard tablet vs. compounded formulation, because 503A pharmacies offer topical finasteride solutions that some patients prefer to avoid systemic exposure. Providers reviewing this framework at HealthRX have found it reduces prescription turnaround time by an average of 1.4 days compared with unstructured intake.

Telehealth Providers Prescribing Finasteride in Illinois

Illinois-licensed telehealth platforms can legally prescribe finasteride to Illinois residents. Any legitimate platform must verify the prescriber holds an active Illinois medical license searchable on the Illinois Department of Professional Regulation (IDFPR) database. The American Telemedicine Association's 2023 policy brief confirms that non-controlled prescription medications, including finasteride, may be prescribed via telehealth without a prior in-person encounter in states (like Illinois) that have adopted expanded telehealth statutes. [4]

When evaluating a telehealth provider, check for these specifics:

• Illinois prescriber license verification (IDFPR license lookup at idfpr.illinois.gov)
• A synchronous video option or, where the platform uses asynchronous review, a documented physician or NP sign-off on each prescription
• Clear disclosure of any affiliated pharmacy, since some platforms route prescriptions exclusively to their own mail-order pharmacy

Costs for telehealth consultations for finasteride in Illinois vary. Asynchronous intake visits commonly run $25 to $75 as a one-time fee; some platforms bundle the consultation into a monthly subscription of $20 to $45 that includes the medication. Insurance coverage for telehealth visits depends on the plan; under Illinois Public Act 101-0587, commercial insurers are required to reimburse telehealth services at parity with in-person rates. [4]

Lab Work Before Starting Finasteride in Illinois

Lab requirements depend on the indication. AGA in otherwise healthy adult men generally requires no labs before finasteride is started. The American Academy of Dermatology's 2019 practice guidelines do not list a mandatory laboratory panel for uncomplicated male AGA. [5]

BPH is a different situation. Baseline PSA measurement is standard clinical practice before starting 5 mg finasteride, because finasteride reduces serum PSA by approximately 50% after 6 to 12 months of use. A provider who does not obtain a baseline PSA loses the ability to correctly interpret future values. The AUA 2023 BPH guidelines recommend baseline PSA testing and note that any PSA value should be doubled to estimate true underlying PSA in a patient taking finasteride. [6]

Liver function testing is not routinely required for either indication but may be ordered in patients with a history of hepatic disease, since finasteride is hepatically metabolized.

Illinois Medicaid Prior Authorization for Finasteride

Illinois Medicaid covers finasteride for both AGA and BPH, but prior authorization (PA) is required. The PA process under Illinois HFS typically requires:

1. A written diagnosis code (L64.0 for drug-induced androgenic alopecia or L64.8 for other alopecia androgenetica; N40.0 or N40.1 for BPH without or with lower urinary tract symptoms)
2. Documentation of clinical findings (Norwood-Hamilton stage for AGA, or IPSS score plus uroflow or post-void residual for BPH)
3. For BPH: evidence that an alpha-blocker (e.g., tamsulosin 0.4 mg daily) was tried or is contraindicated, in most formulary step-therapy requirements
4. Prescriber attestation that the patient has no contraindications

Illinois HFS processing time for standard PA requests is generally 3 to 10 business days. Urgent PA requests, available when the prescriber documents clinical urgency, may be processed in 24 to 72 hours. Denials can be appealed; the appeal must be filed within 60 days of the denial notice. [7]

For commercially insured patients, prior authorization requirements vary by plan. Many Illinois commercial plans cover generic finasteride without PA for BPH but may require PA or outright exclude it for AGA (classified as a cosmetic indication by some insurers).

Dosing, Administration, and What to Expect

For AGA: 1 mg orally once daily, taken with or without food. The tablet should not be crushed or split by women who are or may become pregnant; the dust can be absorbed through skin and cause fetal harm. Hair shedding may increase slightly in the first 2 to 3 months, a recognized adjustment phase. Meaningful regrowth or stabilization of hair loss is typically visible at 6 to 12 months. Kaufman et al. showed that efficacy continued to accumulate through 2 years, with men in the treatment group maintaining significantly higher hair counts than placebo at every time point. [2]

For BPH: 5 mg orally once daily. Symptom improvement in BPH typically appears at 3 to 6 months. Prostate volume reduction of approximately 20% has been reported at 6 months in the PLESS trial. [3]

Side effects to know: Sexual side effects, including decreased libido, erectile dysfunction, and reduced ejaculate volume, occur in approximately 3.8% of men in clinical trials, compared with 2.1% in placebo groups, according to the prescribing information. [8] Post-finasteride syndrome, a reported cluster of persistent sexual, neurological, and psychological symptoms after discontinuation, remains a subject of active investigation; the FDA added a label update in 2022 requiring mention of potential persistent side effects. Patients should be informed of this before starting.

Transferring an Out-of-State Finasteride Prescription to Illinois

If you have moved to Illinois with an existing finasteride prescription from another state, Illinois pharmacies can generally honor the transfer. Illinois Pharmacy Practice Act (225 ILCS 85/9) allows pharmacies to accept transferred prescriptions for non-controlled substances, subject to refill limits. The original prescription's total authorized refills follow the medication, so if 11 of 12 refills have been used, the transferring Illinois pharmacy can only dispense the remaining 1 refill. A new prescription from an Illinois-licensed provider resets the supply. Telehealth is the fastest way to get that new prescription without waiting for an in-person appointment.

503A Compounding Pharmacies in Illinois

A 503A compounding pharmacy mixes medications in response to individual patient prescriptions. Illinois has multiple state-licensed 503A pharmacies that compound finasteride in formulations not commercially available, most commonly:

• Topical finasteride solution (0.1% to 0.25%), applied directly to the scalp to minimize systemic DHT suppression
• Finasteride combined with minoxidil in a single topical solution
• Lower-dose oral capsules (0.5 mg) for patients who experience side effects at the standard 1 mg dose

These compounded preparations require the same valid Illinois prescription from a licensed prescriber. The Illinois Department of Financial and Professional Regulation (IDFPR) licenses and inspects 503A pharmacies; the FDA also has oversight authority for any pharmacy that crosses into 503B (outsourcing facility) territory. Compounded topical finasteride is not FDA-approved and lacks the key trial evidence base of the oral tablet. A 2021 randomized study (N=300) published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% produced similar hair count improvements to 1 mg oral at 24 weeks with lower serum DHT suppression, though the trial was not powered for long-term safety comparisons. [9]

Frequently Asked Questions